Soluble Urokinase Plasminogen Activator Receptor Is Associated With Subclinical Myocardial Impairment by Speckle Tracking Echocardiography in Lung Cancer Patients

BACKGROUND: Plasma cardiac biomarkers have emerged as a cost-effective diagnostic tool aimed at early identification of cardiotoxicity. Soluble urokinase plasminogen activator receptor (suPAR) is a bone marrow cell derived signaling molecule that is associated with cardiovascular disease outcomes. O...

Descripción completa

Detalles Bibliográficos
Autores principales: Manshad, Ahmad S., Ballout, Fatima A., Borgia, Jeffrey A., Reiser, Jochen, Okwuosa, Tochukwu M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831744/
https://www.ncbi.nlm.nih.gov/pubmed/35155590
http://dx.doi.org/10.3389/fcvm.2021.659524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831744/
https://www.ncbi.nlm.nih.gov/pubmed/35155590
http://dx.doi.org/10.3389/fcvm.2021.659524

Ejemplares similares